ArticleProceedings of the National Academy of Sciences of the United States of America2021

Highly active engineered IgG3 antibodies against SARS-CoV-2.

Somanath Kallolimath et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.